Jean-François Rodier
Research Subjects
Research Interests
Jean-François Rodier has a total of 156 co-authors. Here are the top co-authors by number of shared publications:
J C Janser
38 shared publicationsD Rodier
24 shared publicationsE Navarrete
9 shared publicationsJ Pusel
9 shared publications- J P Ghnassia
CLCC Paul Strauss, Strasbourg
6 shared publications B Auge
5 shared publications
Latest Publications
- 1 March 2013
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 39 (3) , 248-254
Pure tubular carcinoma of the breast and sentinel lymph node biopsy: A retrospective multi-institutional study of 234 cases
- 1 March 2013
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 39 (3) , 248-254
Pure tubular carcinoma of the breast and sentinel lymph node biopsy: A retrospective multi-institutional study of 234 cases
- 1 January 2012
- Vol. 133 (1) , 27-32
[Acoustic study of sustained vowels made by patients with recurrent nerve paralysis after thyroidectomy].
The objective of this work is to evaluate the consequences of thyroid surgery on the voice of patients suffering from recurrent paralysis. The consequences of the surgery are evaluated using a corpus of sustained vowels in order to identify the various disruptions that this procedure may produce. This research also looks for possible compensatory and/or readjustment strategies that can be used by a patient alone and with the help of speech therapy. Acoustic measurements considered are fundamental frequency (F0), Harmonics-to-Noise Ratio (HNR), and vowel space area. This is a longitudinal study, as all patients are recorded once a month during three months after surgery. Results reveal a modification of all parameters in the early recording stages. However, time and speech therapy contribute to obtaining expected values of the measured parameters, and thus to improvement of vocal quality.
- 1 January 2012
- Vol. 133 (1) , 27-32
[Acoustic study of sustained vowels made by patients with recurrent nerve paralysis after thyroidectomy].
The objective of this work is to evaluate the consequences of thyroid surgery on the voice of patients suffering from recurrent paralysis. The consequences of the surgery are evaluated using a corpus of sustained vowels in order to identify the various disruptions that this procedure may produce. This research also looks for possible compensatory and/or readjustment strategies that can be used by a patient alone and with the help of speech therapy. Acoustic measurements considered are fundamental frequency (F0), Harmonics-to-Noise Ratio (HNR), and vowel space area. This is a longitudinal study, as all patients are recorded once a month during three months after surgery. Results reveal a modification of all parameters in the early recording stages. However, time and speech therapy contribute to obtaining expected values of the measured parameters, and thus to improvement of vocal quality.
- Open Access
- 24 May 2011
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 4 (2) , 255-259
Thoracic Duct Fistula after Thyroid Cancer Surgery: Towards a New Treatment
The use of somatostatin analogs is a new conservative therapeutic approach for the treatment of chyle fistulas developing after thyroid cancer surgery. The combination therapy with a total parenteral nutrition should avoid the high morbidity of are-intervention with an uncertain outcome. This promising trend is supported by the present case report of a chyle leak occurring after total thyroidectomy with central and lateral neck dissection for a papillary carcinoma, which was treated successfully without immediate or distant sequelae.
- 24 May 2011
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 4 (2) , 255-259
Open AccessThoracic Duct Fistula after Thyroid Cancer Surgery: Towards a New Treatment
The use of somatostatin analogs is a new conservative therapeutic approach for the treatment of chyle fistulas developing after thyroid cancer surgery. The combination therapy with a total parenteral nutrition should avoid the high morbidity of are-intervention with an uncertain outcome. This promising trend is supported by the present case report of a chyle leak occurring after total thyroidectomy with central and lateral neck dissection for a papillary carcinoma, which was treated successfully without immediate or distant sequelae.
- 1 April 2009
- Published by Elsevier in Journal de Chirurgie
- Vol. 146 (2) , 226-227
Métastase ganglionnaire cervicale prévalente d’un cancer de l’ovaire : un piège diagnostique
- 1 April 2009
- Published by Elsevier in Journal de Chirurgie
- Vol. 146 (2) , 226-227
Métastase ganglionnaire cervicale prévalente d’un cancer de l’ovaire : un piège diagnostique
- Open Access
- 17 January 2009
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 2 (1) , 1-6
Myeloid Sarcoma of the Uterine Cervix as Presentation of Acute Myeloid Leukaemia after Treatment with Low-Dose Radioiodine for Thyroid Cancer: A Case Report and Review of the Literature
The development of acute myeloid leukaemia after low-dose radioiodine therapy and its presentation as a myeloid sarcoma of the uterine cervix are both rare events. We report a case of acute myeloid leukaemia revealed by a myeloid sarcoma of the uterine cervix in a 48-year-old woman, 17 months after receiving a total dose of 100 mCi 131I for papillary thyroid cancer. A strict hematological follow-up of patients treated with any dose of 131I is recommended to accurately detect any hematological complications which might have been underestimated. Unusual presentations, such as chloroma of the uterine cervix, may reveal myeloid malignancy and should be kept in mind.
- 17 January 2009
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 2 (1) , 1-6
Open AccessMyeloid Sarcoma of the Uterine Cervix as Presentation of Acute Myeloid Leukaemia after Treatment with Low-Dose Radioiodine for Thyroid Cancer: A Case Report and Review of the Literature
The development of acute myeloid leukaemia after low-dose radioiodine therapy and its presentation as a myeloid sarcoma of the uterine cervix are both rare events. We report a case of acute myeloid leukaemia revealed by a myeloid sarcoma of the uterine cervix in a 48-year-old woman, 17 months after receiving a total dose of 100 mCi 131I for papillary thyroid cancer. A strict hematological follow-up of patients treated with any dose of 131I is recommended to accurately detect any hematological complications which might have been underestimated. Unusual presentations, such as chloroma of the uterine cervix, may reveal myeloid malignancy and should be kept in mind.
- 1 September 2008
- Published by Elsevier in Annales d'Otolaryngologie et de Chirurgie Cervico-faciale
- Vol. 125 (4) , 198-203
Métastase intrathyroïdienne localement avancée d’un cancer bronchique
- 1 September 2008
- Published by Elsevier in Annales d'Otolaryngologie et de Chirurgie Cervico-faciale
- Vol. 125 (4) , 198-203
Métastase intrathyroïdienne localement avancée d’un cancer bronchique
- 20 August 2007
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (24) , 3664-3669
Prospective Multicentric Randomized Study Comparing Periareolar and Peritumoral Injection of Radiotracer and Blue Dye for the Detection of Sentinel Lymph Node in Breast Sparing Procedures: FRANSENODE Trial
Purpose To determine the optimal injection path for blue dye and radiocolloid for sentinel lymph node (SLN) biopsy in early breast cancer. Patients and Methods A prospective randomized multicentric study was initiated to compare the peritumoral (PT) injection site to the periareolar (PA) site in 449 patients. Results The detection rate of axillary SLN by lymphoscintigraphy was significantly higher (P = .03) in the PA group (85.2%) than in the PT group (73.2%). Intraoperative detection rate by blue dye and/or gamma probe was similar (99.11%) in both groups. The rate of SLN detection was somewhat higher in the PA group than in the PT group: 95.6% versus 93.8% with blue dye (P = .24) and 98.2% versus 96.0% by probe (P = .16), respectively. The number of SLNs detected by lymphoscintigraphy and by probe was significantly higher in the PA group than in the PT group, 1.5 versus 1.2 (P = .001) and 1.9 versus 1.7 (P = .02). The blue and hot concordance was 95.6% in the PA group and 91.5% in the PT group (P = .08). The mean ex vivo count of the SLN was significantly higher in the PA group than in the PT group (P < .0001). Conclusion This study strongly validates the PA injection technique given the high detection rate (99.1%) of SLN and the high concordance (95.6%) between blue dye and the radiotracer, as well as higher significant ex and in vivo counts, improving SLN probe detection.
- 20 August 2007
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (24) , 3664-3669
Prospective Multicentric Randomized Study Comparing Periareolar and Peritumoral Injection of Radiotracer and Blue Dye for the Detection of Sentinel Lymph Node in Breast Sparing Procedures: FRANSENODE Trial
Purpose To determine the optimal injection path for blue dye and radiocolloid for sentinel lymph node (SLN) biopsy in early breast cancer. Patients and Methods A prospective randomized multicentric study was initiated to compare the peritumoral (PT) injection site to the periareolar (PA) site in 449 patients. Results The detection rate of axillary SLN by lymphoscintigraphy was significantly higher (P = .03) in the PA group (85.2%) than in the PT group (73.2%). Intraoperative detection rate by blue dye and/or gamma probe was similar (99.11%) in both groups. The rate of SLN detection was somewhat higher in the PA group than in the PT group: 95.6% versus 93.8% with blue dye (P = .24) and 98.2% versus 96.0% by probe (P = .16), respectively. The number of SLNs detected by lymphoscintigraphy and by probe was significantly higher in the PA group than in the PT group, 1.5 versus 1.2 (P = .001) and 1.9 versus 1.7 (P = .02). The blue and hot concordance was 95.6% in the PA group and 91.5% in the PT group (P = .08). The mean ex vivo count of the SLN was significantly higher in the PA group than in the PT group (P < .0001). Conclusion This study strongly validates the PA injection technique given the high detection rate (99.1%) of SLN and the high concordance (95.6%) between blue dye and the radiotracer, as well as higher significant ex and in vivo counts, improving SLN probe detection.
- 31 December 2006
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 32 (10) , 1249
Breast specimen lumpectomy orientation: Which technique is the best?
- 31 December 2006
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 32 (10) , 1249
Breast specimen lumpectomy orientation: Which technique is the best?
- 1 October 2005
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 66 (5) , 485
P209 Faut-il encore considerer les carcinomes thyroïdiens papillaires d’architecture vésiculaire comme des carcinomes papillaires ?
- 1 October 2005
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 66 (5) , 485
P209 Faut-il encore considerer les carcinomes thyroïdiens papillaires d’architecture vésiculaire comme des carcinomes papillaires ?
- 31 October 2004
- Published by Elsevier in Journal de Gynécologie Obstétrique et Biologie de la Reproduction
- Vol. 33 (6) , 543-544
Utilisation de la procédure sentinelle exclusive pour le staging ganglionnaire des cancers micro-invasifs du sein : à propos de cinq cas
- 31 October 2004
- Published by Elsevier in Journal de Gynécologie Obstétrique et Biologie de la Reproduction
- Vol. 33 (6) , 543-544
Utilisation de la procédure sentinelle exclusive pour le staging ganglionnaire des cancers micro-invasifs du sein : à propos de cinq cas